Interestingly, upon further inspection, a significant downregulation of PPARGC1B and PPRC1 transcript levels was shown in COPD GOLDIV patients compared to non-COPD patients (Fig. 1B). Here, PPARGC1B is linked to chronic obstructive pulmonary disease.